• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

DrFirst Partners with Greenway to Bring Controlled Substance E-prescribing to Greenway Users Nationwide

by Jasmine Pennic 02/24/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

DrFirst, a leading provider of healthcare IT solutions designed to improve clinical outcomes for patients, today announced a partnership to bring electronic prescribing of controlled substances (EPCS) to Greenway’s network of thousands of healthcare providers across primary care and more than 30 specialties.

U.S. providers are increasingly prescribing controlled substances electronically in order to improve safety, efficiency and security. Controlled substance e-prescribing, which is now legal in 47 states and available through nearly one-third of U.S. pharmacies, will become mandatory in the state of New York by March 27, 2015 due to the Internet System for Tracking Over-Prescribing/Prescription Monitoring Program (I-STOP) legislation.

DrFirst’s EPCS Gold℠ 2.0 software will be integrated into Greenway’s Intergy, PrimeSUITE and SuccessEHS systems.

“We chose DrFirst for controlled substance e-prescribing based on its industry-leading expertise, its total-solution support covering the identity proofing process, token management and end-user onboarding, as well as the flexibility of its technology which will enable us to integrate EPCS Gold into all three of our EHR software platforms,” said Mark Janiszewski, Greenway senior vice president of product management.

“DrFirst’s architecture allows us to rapidly integrate and bring controlled substance e-prescribing to our users with a consistent and simple user interface,” he continued. “Since EPCS Gold is also fully compliant with DEA rules and NIST identity-proofing standards, DrFirst’s solution brings our users tremendous value.”

“With the increased scrutiny by the healthcare industry on prescription drug abuse, EPCS Gold provides Greenway customers with a powerful tool to prevent doctor shopping and prescription drug fraud,” said G. Cameron Deemer, president of DrFirst. “As a progressive healthcare technology company, Greenway recognizes and embraces the importance of bringing controlled substance e-prescribing to its users, and delivering the advantage of a single e-prescribing workflow for both legend and controlled drugs.”

To download DrFirst’s 2014 report on electronic prescribing of controlled substances, “The Evolving Landscape for Electronic Prescribing of Controlled Substances (EPCS) — An Industry Briefing for 2014,” visit http://go.drfirst.com/EPCSreport2014.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |